Association of meds-to-beds delivery with fewer readmissions at an academic medical center

Clicks: 5
ID: 324616
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #68 of 143 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 143 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Purpose Published data have shown that meds-to-beds programs may improve patient satisfaction and generate revenue, but the results for readmissions have been mixed. The purpose of this study was to assess the impact of a meds-to-beds program on readmissions. Methods This single-center, retrospective cohort study, including adult patients discharged between January 1 and July 30, 2022, compared patients in a meds-to-beds program to patients who did not receive medications through the program. Patients who had data missing, were discharged from an intensive care unit, were not admitted to an inpatient unit, had a nonmedication discharge prescription, or were pregnant were excluded. Patients in the non–meds-to-beds group who filled their prescriptions at the institution’s outpatient pharmacy were also excluded. For the primary outcome, the rate of readmission to the emergency department (ED) or hospital within 30 days was modeled using logistic regression. Secondary outcomes included the rates of readmission within 7 days and 60 days, along with economic measures. Results A total of 768 patients were included in the study, with 384 patients in each group. A lower proportion of patients in the meds-to-beds group had a readmission within 30 days than those in the non–meds-to-beds group (13.3% vs 27.1%, respectively; P < 0.001). Patients in the meds-to-beds group also had a lower readmission rate at 7 days (P < 0.001) and 60 days (P = 0.001). The total marginal profit from the meds-to-beds program was $30,253 over a 7-month period. Conclusion The meds-to-beds program was associated with fewer readmissions to the ED or hospital within 7 days, 30 days, and 60 days and generated revenue for the institution’s outpatient pharmacy.
Reference Key
openalex_W7202203080 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Natalie Delozier, Nicole Metzger, Marion Javellana, Christopher O’Donnell, Hila Calev, Sathyabama Naidu, Vena Crichlow, Traci Leong, Nicholas Michaud, Carrie Tilton Callahan
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag240
URL
https://doi.org/10.1093/ajhp/zxag240
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.